Free Trial

Amphastar Pharmaceuticals (AMPH) SEC Filings & 10K Form

Amphastar Pharmaceuticals logo
$44.61 -0.45 (-1.00%)
(As of 11/15/2024 ET)

Recent Amphastar Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/13/2024
7:26 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
5:55 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
7:05 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
12:29 PM
Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
12:29 PM
Amphastar Pharmaceuticals (Subject)
Zhou Rong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
6:02 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
6:09 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
6:48 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:48 PM
Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
8:33 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
4:26 PM
Amphastar Pharmaceuticals (Subject)
Zhou Rong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
4:58 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:25 PM
Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:15 PM
Amphastar Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:22 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
3:32 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
4:24 PM
Amphastar Pharmaceuticals (Subject)
PETERS WILLIAM J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2024
3:26 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:25 PM
Amphastar Pharmaceuticals (Subject)
PETERS WILLIAM J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
5:35 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
5:32 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:51 PM
Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
7:10 PM
Amphastar Pharmaceuticals (Issuer)
Lee Howard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:54 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:56 PM
Amphastar Pharmaceuticals (Issuer)
Deflin Gayle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:03 PM
Amphastar Pharmaceuticals (Issuer)
Gerst Diane G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:56 PM
Amphastar Pharmaceuticals (Issuer)
ZASLOFF MICHAEL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:58 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:00 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
5:26 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:56 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
3:21 PM
Amphastar Pharmaceuticals (Filer)
Form DEFA14A
04/12/2024
3:08 PM
Amphastar Pharmaceuticals (Filer)
Form DEF 14A
04/12/2024
3:08 PM
Amphastar Pharmaceuticals (Filer)
Form DEF 14A
04/12/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form DEFA14A
04/12/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form DEFA14A
04/02/2024
8:31 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:55 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:47 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
03/08/2024
3:49 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:52 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:32 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:54 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:57 PM
Amphastar Pharmaceuticals (Issuer)
ZASLOFF MICHAEL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:29 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:49 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:51 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
9:23 AM
Amphastar Pharmaceuticals (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G/A
03/05/2024
12:21 PM
Amphastar Pharmaceuticals (Subject)
ZASLOFF MICHAEL A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
7:35 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:53 PM
Amphastar Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
3:38 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
4:21 PM
Amphastar Pharmaceuticals (Subject)
Zhang Jack Y. (Filed by)
Form SC 13G/A
02/02/2024
6:37 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
10:53 AM
Amphastar Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/17/2024
1:36 PM
Amphastar Pharmaceuticals (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G/A
01/11/2024
3:37 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
5:27 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:25 PM
Amphastar Pharmaceuticals (Subject)
Luo Mary Z. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:22 PM
Amphastar Pharmaceuticals (Subject)
Luo Mary Z. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:23 PM
Amphastar Pharmaceuticals (Subject)
Luo Mary Z. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/03/2024
6:25 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:25 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:49 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:11 PM
Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2023
4:23 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
11:34 AM
Amphastar Pharmaceuticals (Subject)
Zhou Rong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AMPH) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners